But the news that more studies are underway with groups of 200 rats that will continue the c60/evoo treatment until death is likely to answer that definitively.
NO !!! AGAIN, NO!!! We HOPE that the ITP will accept to do the study.
To me, the difference is huge and
IT IS VERY IMPORTANT TO UNDERSTAND IT for the cause: because there are MANY things to test on lifespan every year, and VERY FEW robust lifespan tests are actually been done. I consider it to be
THE BOTTLENECK OF LIFE EXTENSION SCIENCE. Especially with the current state of knowledge where we don't know in advance what will extend lifespan or not:
we need much more of such tests to guide the development of anti-aging strategies, otherwise most research is wishful thinking.
If you are not convinced look at the limited number of tests done by the ITP since 2004:
http://www.nia.nih.g...mpounds-testing Think of the few robust additional lifespan tests you've read about (robust I said: 10 ?): think of Spindler's studies that have not been published over the last 1.5 year or so (why is taking so long?). Compare this small number with all the promising compounds that we think should be tested every month... I wish a generous donator enters and allows many more tests.
But this should headline anti-cancer news
Pr Baati now has become a good friend but it is not published and not repeated yet, so let's wait for similar conclusions to be repeated before shouting. To be efficient, science requires some robust testing, if you don't want to build on sand and discover later that you have to unconstruct all and build at a new place, with moderate credibility.
Edited by AgeVivo, 27 October 2012 - 08:26 PM.